327 related articles for article (PubMed ID: 3071794)
1. Aberration in de novo ether lipid biosynthesis in peroxisomal disorders.
van den Bosch H; Schalkwijk CG; Schrakamp G; Wanders RJ; Schutgens RB; Schram AW; Tager JM
Prog Clin Biol Res; 1988; 282():139-50. PubMed ID: 3071794
[TBL] [Abstract][Full Text] [Related]
2. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors.
Schrakamp G; Schalkwijk CG; Schutgens RB; Wanders RJ; Tager JM; van den Bosch H
J Lipid Res; 1988 Mar; 29(3):325-34. PubMed ID: 3379344
[TBL] [Abstract][Full Text] [Related]
3. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes.
Tager JM; Brul S; Wiemer EA; Strijland A; Van Driel R; Schutgens RB; Van den Bosch H; Wanders RJ; Westerveld A
Prog Clin Biol Res; 1990; 321():545-58. PubMed ID: 2183242
[TBL] [Abstract][Full Text] [Related]
4. The role of peroxisomes in glycerol ether lipid metabolism.
Hajra AK; Horie S; Webber KO
Prog Clin Biol Res; 1988; 282():99-116. PubMed ID: 3071810
[TBL] [Abstract][Full Text] [Related]
5. Plasmalogen biosynthesis in the diagnosis of peroxisomal disorders.
Kremser K; Roscher A
J Clin Chem Clin Biochem; 1989 May; 27(5):315-7. PubMed ID: 2760566
[TBL] [Abstract][Full Text] [Related]
6. Glyceryl ethers in peroxisomal disease.
Poulos A; Bankier A; Beckman K; Johnson D; Robertson EF; Sharp P; Sheffield L; Singh H; Usher S; Wise G
Clin Genet; 1991 Jan; 39(1):13-25. PubMed ID: 1705185
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes.
Datta NS; Wilson GN; Hajra AK
N Engl J Med; 1984 Oct; 311(17):1080-3. PubMed ID: 6566965
[TBL] [Abstract][Full Text] [Related]
8. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis.
Brul S; Westerveld A; Strijland A; Wanders RJ; Schram AW; Heymans HS; Schutgens RB; van den Bosch H; Tager JM
J Clin Invest; 1988 Jun; 81(6):1710-5. PubMed ID: 2454948
[TBL] [Abstract][Full Text] [Related]
9. Peroxisomal disorders: clinical commentary and future prospects.
Wilson GN; Holmes RD; Hajra AK
Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077
[TBL] [Abstract][Full Text] [Related]
10. Genetic diseases caused by peroxisomal dysfunction. New findings in clinical and biochemical studies.
Schutgens RB; Wanders RJ; Nijenhuis A; van den Hoek CM; Heymans HS; Schrakamp G; Bleeker-Wagemakers EM; Delleman JW; Schram AW; Tager JM
Enzyme; 1987; 38(1-4):161-76. PubMed ID: 3440444
[TBL] [Abstract][Full Text] [Related]
11. [Peroxisomes and neurologic diseases].
Sereni C; Paturneau-Jouas M
Rev Neurol (Paris); 1989; 145(5):341-9. PubMed ID: 2472665
[TBL] [Abstract][Full Text] [Related]
12. Peroxisomal disorders in neurology.
Wanders RJ; Heymans HS; Schutgens RB; Barth PG; van den Bosch H; Tager JM
J Neurol Sci; 1988 Dec; 88(1-3):1-39. PubMed ID: 3066850
[TBL] [Abstract][Full Text] [Related]
13. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ
J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
[TBL] [Abstract][Full Text] [Related]
14. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
[TBL] [Abstract][Full Text] [Related]
15. Ether lipid synthesis and its deficiency in peroxisomal disorders.
van den Bosch H; Schrakamp G; Hardeman D; Zomer AW; Wanders RJ; Schutgens RB
Biochimie; 1993; 75(3-4):183-9. PubMed ID: 8507680
[TBL] [Abstract][Full Text] [Related]
16. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.
Hoefler G; Paschke E; Hoefler S; Moser AB; Moser HW
J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949
[TBL] [Abstract][Full Text] [Related]
17. Aberrant subcellular localization of peroxisomal 3-ketoacyl-CoA thiolase in the Zellweger syndrome and rhizomelic chondrodysplasia punctata.
Balfe A; Hoefler G; Chen WW; Watkins PA
Pediatr Res; 1990 Mar; 27(3):304-10. PubMed ID: 2181395
[TBL] [Abstract][Full Text] [Related]
18. Differential deficiency of mevalonate kinase and phosphomevalonate kinase in patients with distinct defects in peroxisome biogenesis: evidence for a major role of peroxisomes in cholesterol biosynthesis.
Wanders RJ; Romeijn GJ
Biochem Biophys Res Commun; 1998 Jun; 247(3):663-7. PubMed ID: 9647750
[TBL] [Abstract][Full Text] [Related]
19. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
[TBL] [Abstract][Full Text] [Related]
20. Major peroxisomal membrane polypeptides are synthesized in cultured skin fibroblasts from patients with Zellweger syndrome.
Suzuki Y; Shimozawa N; Orii T; Hashimoto T
Pediatr Res; 1989 Aug; 26(2):150-3. PubMed ID: 2771521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
